Skip to main content
TTrialFinderData
TrialFinderData is for informational purposes only and does not provide medical advice. Always talk to your doctor.

COPD Exacerbation Clinical Trials

Reviewed by TrialFinderData Editorial Team · Updated

5 recruiting trials for COPD Exacerbation. Eligibility criteria explained in plain English.

TrialFinderData lists 5 COPD Exacerbation clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.

Research is led by Alexis FERRE (1), Istituti Clinici Scientifici Maugeri SpA (1), Saglik Bilimleri Universitesi (1), among the most active sponsors registered for these trials.

The most frequently studied intervention is register (other, 1 trial), followed by HIRT, HIET.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
5
Total Trials
5
Recruiting Now
0
Phase 3 Trials
5
Sponsors

Track COPD Exacerbation trials

Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT06257329

Patients With Severe Acute Exacerbation of COPD Ans Admitted in ICU Register.

The objective of this prospective observational study is to describe the epidemiological, clinical and biological characteristics of admitted patients in ICU for severe acute...

Sponsor: Alexis FERREEnrolling: 20002 locations
RECRUITINGNCT07302425

High-intensity Resistance Training in Post-exacerbation COPD

After a COPD exacerbation, many individuals experience severe weakness in the leg muscles, especially the quadriceps. This weakness can make daily activities difficult and slow...

Sponsor: Istituti Clinici Scientifici Maugeri SpAEnrolling: 641 location
RECRUITINGNCT05738720

Effect of Home Based Pulmonary Rehabilitation on Exacerbation and Hospital Admission in Severe COPD

The study is a randomized controlled trial. The cases will be divided into two groups as the Homespirometer group and the control group. Breathing exercises, aerobic exercise and...

Sponsor: Saglik Bilimleri UniversitesiEnrolling: 241 location
RECRUITINGNCT03890224

Respiratory Support in Chronic Obstructive Pulmonary Disease (COPD) Patients

The hypothesis of this study is that any of 3 modalities of home non- invasive ventilation (NIV) compared to 'no NIV' (=hospital NIV) will reduce re-admission to hospital or death...

Sponsor: ClinactEnrolling: 4001 location
RECRUITINGNCT06304207

Telehealth and Onsite Maintenance Exercise in Chronic Lung Disease

The goal of this pilot clinical trial is to compare telehealth and onsite supervised maintenance exercise program for adults with Chronic Lung Disease. The specific aims of the...

Sponsor: MGH Institute of Health ProfessionsEnrolling: 301 location

Frequently Asked Questions

There are currently 5 clinical trials for COPD Exacerbation, with 5 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for COPD Exacerbation, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for COPD Exacerbation, representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.